| Income Statement |
| Total Revenue | 3.90M |
|
| Revenues (USD) | 3.90M |
| Cost of Revenue | 1.92M |
| Gross Profit | 1.98M |
| Operating Expenses | 10.54M |
| Research and Development Expense | 3.85M |
| Selling, General and Administrative Expense | 6.69M |
| Operating Income | -8.56M |
| Interest Expense | 83.00K |
| Net Income | -8.62M |
| Net Income Common Stock | -8.62M |
| Net Income Common Stock (USD) | -8.62M |
| Consolidated Income | -8.62M |
| Earnings per Basic Share | -0.09 |
| Earnings per Basic Share (USD) | -0.09 |
| Earnings per Diluted Share | -0.09 |
| Earning Before Interest & Taxes (EBIT) | -8.54M |
| Earning Before Interest & Taxes (USD) | -8.54M |
| Weighted Average Shares | 97.70M |
| Weighted Average Shares Diluted | 97.70M |
| Balance Sheet |
| Cash and Equivalents | 41.28M |
| Cash and Equivalents (USD) | 41.28M |
| Trade and Non-Trade Receivables | 5.80M |
| Current Assets | 56.03M |
| Property, Plant & Equipment Net | 2.50M |
| Total Assets | 60.34M |
| Total Debt | 13.12M |
| Current Liabilities | 10.15M |
| Debt Non-Current | 13.12M |
| Total Liabilities | 25.98M |
| Accumulated Retained Earnings (Deficit) | -338.64M |
| Shareholders Equity | 34.36M |
| Shareholders Equity (USD) | 34.36M |
| Assets Non-Current | 4.31M |
| Total Debt (USD) | 13.12M |
| Deferred Revenue | 2.29M |
| Inventory | 6.33M |
| Liabilities Non-Current | 15.82M |
| Trade and Non-Trade Payables | 4.61M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 274.00K |
| Net Cash Flow from Financing | 14.49M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.24M |
| Capital Expenditure | -242.00K |
| Issuance (Purchase) of Equity Shares | 845.00K |
| Issuance (Repayment) of Debt Securities | 13.64M |
| Net Cash Flow from Investing | -242.00K |
| Net Cash Flow from Operations | -9.01M |
| Share Based Compensation | 647.00K |